NASDAQ:IRMD - Iradimed Stock Price, Forecast & News

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

Iradimed Corp (NASDAQ:IRMD) released its quarterly earnings data on Thursday, February, 6th. The medical equipment provider reported $0.30 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.10. The medical equipment provider had revenue of $10.89 million for the quarter, compared to the consensus estimate of $10.96 million. Iradimed had a return on equity of 18.95% and a net margin of 25.01%. View Iradimed's Earnings History.

Iradimed is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Iradimed.

Iradimed updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 6th. The company provided earnings per share guidance of 0.84-0.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.92. The company issued revenue guidance of $46.3-47.1 million, compared to the consensus revenue estimate of $46.96 million.

Media coverage about IRMD stock has been trending somewhat positive this week, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Iradimed earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Iradimed.

Iradimed saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 500,800 shares, an increase of 8.7% from the January 15th total of 460,900 shares. Based on an average trading volume of 65,300 shares, the short-interest ratio is presently 7.7 days. Currently, 9.3% of the shares of the company are short sold. View Iradimed's Current Options Chain.

Some companies that are related to Iradimed include Tactile Systems Technology (TCMD), Luminex (LMNX), Cryolife (CRY), Axonics Modulation Technologies (AXNX), Orthofix Medical (OFIX), Cerus (CERS), Orthopediatrics (KIDS), MiMedx Group (MDXG), Intersect ENT (XENT), Anika Therapeutics (ANIK), LeMaitre Vascular (LMAT), Antares Pharma (ATRS), SurModics (SRDX), SI-Bone (SIBN) and AngioDynamics (ANGO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), Paypal (PYPL), Alphabet (GOOG), Mastercard (MA), Palo Alto Networks (PANW), Verizon Communications (VZ), Align Technology (ALGN) and IntriCon (IIN).

Iradimed's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (4.65%), Russell Investments Group Ltd. (2.39%), Cadence Capital Management LLC (0.93%), Parkman Healthcare Partners LLC (0.81%), Geode Capital Management LLC (0.60%) and Marshall Wace LLP (0.58%). Company insiders that own Iradimed stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, Francis X Casey, John K Mccreery, Louis S Waldman, Monty K Allen, Roger E Susi and Steven M Nardi. View Institutional Ownership Trends for Iradimed.

IRMD stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, AQR Capital Management LLC, Bank of America Corp DE, Cadence Capital Management LLC, Chicago Equity Partners LLC, Navellier & Associates Inc and Fiera Capital Corp. Company insiders that have sold Iradimed company stock in the last year include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen and Steven M Nardi. View Insider Buying and Selling for Iradimed.

IRMD stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Renaissance Technologies LLC, Parkman Healthcare Partners LLC, Rice Hall James & Associates LLC, Bank of Montreal Can, Oxford Asset Management LLP, Algert Global LLC and Acadian Asset Management LLC. View Insider Buying and Selling for Iradimed.

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IRMD stock can currently be purchased for approximately $26.11.

Iradimed has a market capitalization of $299.74 million and generates $38.52 million in revenue each year. The medical equipment provider earns $9.63 million in net income (profit) each year or $0.78 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

The official website for Iradimed is http://www.iradimed.com/.

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]